Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Abcam stock | $22.9

Learn how to easily invest in Abcam stock.

Abcam plc
NASDAQ: ABCM - USD
BIOTECHNOLOGY
$22.75
- $0.15 ( - 0.66%)

Abcam plc is a biotechnology business based in the US. Abcam shares (ABCM) are listed on the NASDAQ and all prices are listed in US Dollars. Abcam employs 1,650 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Abcam

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ABCM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Abcam stock price (NASDAQ: ABCM)

Use our graph to track the performance of ABCM stocks over time.

Abcam shares at a glance

Information last updated 2021-10-16.
Latest market close$22.90
52-week range$17.14 - $24.69
50-day moving average $20.76
200-day moving average $19.97
Wall St. target price$1,639.13
PE ratio 220.9184
Dividend yield $0 (0%)
Earnings per share (TTM) $0.10

Buy Abcam shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Abcam stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Abcam price performance over time

Historical closes compared with the close of $22.9 from 2021-10-21

1 week (2021-10-15) 5.77%
1 month (2021-09-22) 8.84%
3 months (2021-07-22) 26.80%
6 months (2021-04-22) 12.37%
1 year (2020-10-22) 15.95%
2 years (2019-10-18) N/A
3 years (2018-10-18) N/A
5 years (2016-10-18) N/A

Is Abcam under- or over-valued?

Valuing Abcam stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abcam's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Abcam's P/E ratio

Abcam's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 221x. In other words, Abcam shares trade at around 221x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Abcam's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.

Abcam's EBITDA

Abcam's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $61 million.

The EBITDA is a measure of a Abcam's overall financial performance and is widely used to measure a its profitability.

To put Abcam's EBITDA into context you can compare it against that of similar companies.

Abcam financials

Revenue TTM $297.7 million
Operating margin TTM 11.29%
Gross profit TTM $211.8 million
Return on assets TTM 2.57%
Return on equity TTM 2.85%
Profit margin 5.44%
Book value $2.81
Market capitalisation $4.9 billion

TTM: trailing 12 months

Shorting Abcam shares

There are currently 129,161 Abcam shares held short by investors – that's known as Abcam's "short interest". This figure is 0.3% up from 128,737 last month.

There are a few different ways that this level of interest in shorting Abcam shares can be evaluated.

Abcam's "short interest ratio" (SIR)

Abcam's "short interest ratio" (SIR) is the quantity of Abcam shares currently shorted divided by the average quantity of Abcam shares traded daily (recently around 52291.902834008). Abcam's SIR currently stands at 2.47. In other words for every 100,000 Abcam shares traded daily on the market, roughly 2470 shares are currently held short.

To gain some more context, you can compare Abcam's short interest ratio against those of similar companies.

However Abcam's short interest can also be evaluated against the total number of Abcam shares, or, against the total number of tradable Abcam shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Abcam's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Abcam shares in existence, roughly 0 shares are currently held short) or 0.0007% of the tradable shares (for every 100,000 tradable Abcam shares, roughly 1 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Abcam.

Find out more about how you can short Abcam stock.

Abcam share dividends

We're not expecting Abcam to pay a dividend over the next 12 months.

You may also wish to consider:

Abcam share price volatility

Over the last 12 months, Abcam's shares have ranged in value from as little as $17.14 up to $24.69. A popular way to gauge a stock's volatility is its "beta".

ABCM.US volatility(beta: 0.58)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abcam's is 0.5824. This would suggest that Abcam's shares are less volatile than average (for this exchange).

To put Abcam's beta into context you can compare it against those of similar companies.

Abcam overview

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; cell line and lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. It also sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. .

Frequently asked questions

What percentage of Abcam is owned by insiders or institutions?
Currently 0.002% of Abcam shares are held by insiders and 10.595% by institutions.
How many people work for Abcam?
Latest data suggests 1,650 work at Abcam.
When does the fiscal year end for Abcam?
Abcam's fiscal year ends in June.
Where is Abcam based?
Abcam's address is: Discovery Drive, Cambridge, United Kingdom, CB2 0AX
What is Abcam's ISIN number?
Abcam's international securities identification number is: US0003802040

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site